Accel is reportedly in advanced discussions to lead a funding round of $30-40 million in Indian online pharmacy, Truemeds.The proposed valuation for Truemeds is around $330 million.The deal is not yet finalized and the terms may still change.Truemeds aims to disrupt the supply chain of medicine by eliminating middlemen and reducing medication costs.